Trends and Patterns of Disparities in Burden of Lung Cancer in the United States, 1974-2015

Yu Jie Zhong, Yi Feng Wen, Hai Ming Wong, Guosheng Yin, Ruitao Lin, Shuan Ying YangFrontiers in Oncology 2019 · DOI

TL;DR

This study analyzes over 40 years of US lung cancer data to reveal persistent disparities in incidence and mortality across demographic groups and cancer types. Despite an overall decline in lung cancer, the progress is uneven, highlighting the need for targeted interventions to address these inequities.

What Problem Does This Paper Address?

Lung cancer remains a leading cause of cancer-related deaths worldwide and in the United States. While public health efforts have led to a general decline in lung cancer incidence and mortality since the 1990s, it's crucial to understand if this progress is uniform across all segments of the population. Previous studies have indicated that disparities exist based on factors like sex, race, age, and cancer subtype. However, updated epidemiological data on these trends and disparities are needed to inform effective public health strategies and achieve the goal of eliminating cancer disparities. This paper aims to fill this gap by providing a comprehensive analysis of lung cancer trends and patterns of disparities in the US from 1974 to 2015.

Methods

The researchers utilized data from the Surveillance, Epidemiology, and End Results (SEER) program, specifically the SEER 9 research database, which covers approximately 10% of the US population. They extracted information on lung cancer cases and deaths from 1974 to 2015. Key to their analysis was the calculation of age-standardized lung cancer incidence and mortality rates. They employed joinpoint regression modeling to estimate annual percent changes (APCs) and average annual percent changes (AAPCs) to identify significant trends and turning points in these rates. This analysis was performed across various demographic variables (sex, race, age) and tumor characteristics, including histologic types (small cell carcinoma, adenocarcinoma, squamous cell carcinoma) and cancer stages (SEER Historic Stage A and AJCC/TNM staging systems).

Datasets

The primary dataset used in this study is the SEER 9 research database. This database contains de-identified data on lung cancer cases and deaths from nine long-standing, high-quality, population-based cancer registries in the United States, representing approximately 10% of the total US population. The data spans from 1974 to 2015 for incidence and from 1989 to 2015 for incidence-based mortality.

Key Insights and Ideas

  • Uneven Progress: The overall decline in lung cancer is a success, but the "extent to which such progress has been made is unequal across population segments." This underscores that broad public health messages might not be sufficient.
  • Shifting Gender Dynamics in Young Adults: While lung cancer incidence has generally declined, a notable finding is the shift in younger adults (20-39 years). Females had higher incidence from 1995-2011, but a faster decline in recent years has led to lower incidence among females in this age group. This suggests complex interplay of factors beyond just smoking initiation timing.
  • Racial Disparities Persist: The study confirms that racial disparities in lung cancer burden continue. Notably, Black males and females consistently show a higher incidence of squamous cell carcinoma compared to white males and females.
  • Adenocarcinoma's Unique Trajectory: Adenocarcinoma is the only histologic type with a non-decreasing incidence and mortality rate over the study period, becoming the most common type of lung cancer. A particularly interesting finding is the plateauing incidence of adenocarcinoma in Black females since 2012, a group that previously saw a faster increase.
  • The Elderly Burden: As the US population ages, the burden of lung cancer is increasingly concentrated among the elderly (octogenarians and older). A concerning trend is the plateauing incidence of early-stage lung cancer in this group, while mortality continues to rise, suggesting potential undertreatment.

Key Results

  • Overall Incidence Decline: Lung cancer incidence decreased significantly since 1990, with an annual percent change of -0.9% from 1990-2007 and -2.6% from 2007-2015.
  • Gender Gap Narrowing: The gender gap in lung cancer incidence has narrowed considerably. In 1974, males had a 3.7 times higher incidence rate than females; by 2015, this ratio decreased to 1.3.
  • Squamous Cell Carcinoma: Incidence for squamous cell carcinoma decreased significantly. However, Black males and females consistently had a higher incidence than white males and females throughout the study period.
  • Adenocarcinoma: This type showed a non-decreasing incidence (AAPC of 2.0%) and mortality (AAPC of 0.0%). A faster incidence increase was observed among Black females compared to other sex-by-race groups during 2005-2012, but their incidence plateaued after 2012.
  • Elderly Incidence and Mortality: After circa 2005, octogenarians and older patients had the highest lung cancer incidence. For localized and stage I lung cancer in this group, incidence plateaued since 2009, but mortality continued to rise (localized: 1.4% per year; stage I: 6.7% per year).

Limitations and Future Work

The authors acknowledge several limitations:

  • Descriptive Nature: The study is descriptive, making it impossible to rule out ecological fallacy (i.e., drawing conclusions about individuals based on group data).
  • Data Limitations: Inaccuracies in death certificates could affect mortality trend interpretation. The SEER database also oversamples urban and foreign-born populations, potentially limiting generalizability.
  • Missing Data: Crucially, data on smoking behavior, socioeconomic status, and comorbidities were not captured by the SEER database and thus not adjusted for.

Future work should focus on:

  • Elucidating Etiologic Factors: Further research is needed to understand the causes of lung cancer types not strongly associated with smoking, particularly adenocarcinoma.
  • Investigating Undertreatment in the Elderly: The rising mortality in elderly patients with early-stage lung cancer despite plateauing incidence warrants investigation into potential undertreatment and the need for precise clinical guidelines for this population.
  • Addressing Access to Care: The study highlights disparities, and further research should explore how limited access to healthcare among vulnerable populations contributes to these disparities.

Summary updated

Abstract

<b>Background:</b> Although lung cancer incidence and mortality have been declining since the 1990s, the extent to which such progress has been made is unequal across population segments. Updated epidemiologic data on trends and patterns of disparities are lacking. <b>Methods:</b> Data on lung cancer cases and deaths during 1974 to 2015 were extracted from the Surveillance, Epidemiology, and End Results program. Age-standardized lung cancer incidence and mortality and their annual percent changes were calculated by histologic types, demographic variables, and tumor characteristics. <b>Results:</b> Lung cancer incidence decreased since 1990 (1990 to 2007: annual percent change, -0.9 [95% CI, -1.0%, -0.8%]; 2007 to 2015: -2.6 [-2.9%, -2.2%]). Among adults aged between 20 and 39 years, a higher incidence was observed among females during 1995 to 2011, after which a faster decline in female lung cancer incidence (males: -2.5% [-2.8%, -2.2%]; females: -3.1% [-4.7%, -1.5%]) resulted in a lower incidence among females. The white population had a higher incidence than the Black population for small cell carcinoma since 1987. Black females were the only group whose adenocarcinoma incidence plateaued since 2012 (-5.0% [-13.0%, 3.7%]). A higher incidence for squamous cell carcinoma was observed among Black males and females than among white males and females during 1974 to 2015. After circa 2005, octogenarians and older patients constituted the group with the highest lung cancer incidence. Incidence for localized and AJCC/TNM stage I lung cancer among octogenarians and older patients plateaued since 2009, while mortality continued to rise (localized: 1.4% [0.6%, 2.1%]; stage I: 6.7% [4.5%, 9.0%]). <b>Conclusions:</b> Lung cancer disparities prevail across population segments. Our findings inform effective approaches to eliminate lung cancer disparities by targeting at-risk populations.
BibTeX
@inproceedings{zhong2019trends,
  author = {Yu Jie Zhong and Yi Feng Wen and Hai Ming Wong and Guosheng Yin and Ruitao Lin and Shuan Ying Yang},
  title = {{Trends and Patterns of Disparities in Burden of Lung Cancer in the United States, 1974-2015}},
  booktitle = {Frontiers in Oncology},
  year = {2019},
  doi = {10.3389/fonc.2019.00404},
}
Figure